Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
101.50
+1.90 (1.91%)
At close: May 29, 2026, 4:00 PM EDT
102.00
+0.50 (0.49%)
After-hours: May 29, 2026, 7:55 PM EDT
Mirum Pharmaceuticals Employees
Mirum Pharmaceuticals had 418 employees as of March 31, 2026. The number of employees increased by 46 or 12.37% since the number was last reported on December 31, 2025.
Employees
418
Change
46
Growth
12.37%
Revenue / Employee
$1,362,701
Profits / Employee
-$1,911,103
Market Cap
6.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 418 | 46 | 12.37% | 418 | 0 |
| Dec 31, 2025 | 372 | 50 | 15.53% | 369 | 3 |
| Dec 31, 2024 | 322 | 58 | 21.97% | 322 | 0 |
| Dec 31, 2023 | 264 | 68 | 34.69% | 264 | 0 |
| Dec 31, 2022 | 196 | 59 | 43.07% | 196 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Rhythm Pharmaceuticals | 414 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
| Kymera Therapeutics | 253 |
| Celcuity | 155 |
| Protagonist Therapeutics | 131 |
MIRM News
- 3 hours ago - Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026 - Business Wire
- 3 days ago - Mirum Pharmaceuticals Enters Catalyst-Rich Stretch as LIVMARLI Sales and Pipeline Advance - MarketBeat
- 9 days ago - Mirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026 - Business Wire
- 10 days ago - Mirum Pharmaceuticals Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 10 days ago - Mirum Pharma: A Rare Disease Growth Story to Watch - MarketBeat
- 11 days ago - Mirum Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 11 days ago - Mirum Pharmaceuticals initiated with an Outperform at Wolfe Research - TheFly
- 15 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire